Eton Pharmaceuticals (ETON) Net Margin (2019 - 2025)
Eton Pharmaceuticals (ETON) reported Net Margin of 7.97% for Q4 2025, up 1310.0% on a YoY basis from 0.57% in Q4 2024, and up 192.88% sequentially from 8.58% in Q3 2025.
Eton Pharmaceuticals (ETON) Net Margin (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 7 years of Net Margin data on file, last reported at 7.97% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin rose 1310.0% year-over-year to 7.97%; the trailing twelve-month figure through Dec 2025 stood at 5.49% (up 431.0% YoY), and the FY2025 full-year result was 5.49%, up 431.0% from the prior year.
- Net Margin improved to 7.97% in Q4 2025, from 8.58% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 43.0% in Q1 2021 to a low of 786.32% in Q3 2021.
- A 5-year average of 59.44% and a median of 8.84% in 2025 frame the typical range for Net Margin.
- Peak annual rise in Net Margin reached 2358427 bps in 2021, while the deepest fall reached 25621628 bps in 2021.
- Tracing ETON's Net Margin over 5 years: stood at 17.05% in 2021, then surged by 94 bps to 33.02% in 2022, then sank by 119 bps to 6.25% in 2023, then climbed by 18 bps to 5.13% in 2024, then surged by 255 bps to 7.97% in 2025.
- Business Quant data shows ETON's Net Margin at 7.97% in Q4 2025, 8.58% in Q3 2025, and 13.66% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 7.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.97% |
| Sep 30, 2025 | -8.58% |
| Jun 30, 2025 | -13.66% |
| Mar 31, 2025 | -9.10% |
| Dec 31, 2024 | -5.13% |
| Sep 30, 2024 | 6.07% |
| Jun 30, 2024 | -33.51% |
| Mar 31, 2024 | -10.18% |
| Dec 31, 2023 | -6.25% |
| Sep 30, 2023 | -8.24% |
| Jun 30, 2023 | 38.00% |
| Mar 31, 2023 | -50.15% |
| Dec 31, 2022 | 33.02% |
| Sep 30, 2022 | -60.90% |
| Jun 30, 2022 | -31.16% |
| Mar 31, 2022 | -244.94% |
| Dec 31, 2021 | 17.05% |
| Sep 30, 2021 | -786.32% |
| Jun 30, 2021 | -65.73% |
| Mar 31, 2021 | 43.00% |